Sanford-Burnham Medical Research Institute

Researchers identify new target to treat psoriasis

Sanford-Burnham scientists have identified the B and T Lymphocyte Attenuator (BTLA) inhibitory receptor as a key factor in limiting inflammatory responses, particularly in the skin. The study, published online ...

Dec 05, 2013
popularity 5 / 5 (4) | comments 0 | with audio podcast

Team finds new target for melanoma treatment

Scientists at Sanford-Burnham Medical Research Institute (Sanford-Burnham) today announced the discovery that a gene encoding an enzyme, phosphoinositide-dependent kinase-1 (PDK1), plays an essential role in the development ...

Sep 16, 2013
popularity 4 / 5 (1) | comments 0